Back

Intramyocardial bone marrow mononuclear cell injection in patients with ischemic heart disease: a safety evaluation of 333 procedures

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Signal transduction in ischemic heart disease Gene Therapy, Cell Therapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Gerben Van Dijk

Leiden University Medical Center, Leiden (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Professor X. Wang (Melbourne, AU)
Abstract
Presentation thumbnail
Ms P. Ortiz Sanchez (Madrid, ES)
Abstract
Presentation thumbnail
Associate Professor H. Pan (Saint Louis, US)
Abstract Slides
Presentation thumbnail
Doctor J. Winter (Berlin, DE)
Abstract
Presentation thumbnail
Mr S. Bokredenghel (Cologne, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Signal transduction in ischemic heart disease

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
High doses of CD34+ cells delivered to patients in the CardiAMP Heart Failure (HF) trial
29 June 2021
thumbnail
Congress Presentation
Stuck between the layers: a heartfelt mystery unraveled by multimodal imaging
13 December 2025
thumbnail
Webinar
Exosomes - what are they and how can they benefit in ischaemic heart disease?
23 February 2021
thumbnail
Congress Presentation
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources